Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Lupin LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500257NSE Symbol: LUPINP/E(TTM):17.69
ISIN Demat:INE326A01037Div & Yield %:0.59EPS(TTM):115.47
Book Value(Rs):531.5387173Market Cap ( Cr.):93301.24Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 16967.5014666.5011258.8311771.6711055.9311025.66
Excise Duty0.000.000.000.000.000.00
Net Sales16967.5014666.5011258.8311771.6711055.9311025.66
Other Income 253.39115.51210.02216.99129.09475.19
Stock Adjustments 38.3515.93-120.79242.3881.8628.72
Total Income17259.2414797.9411348.0612231.0411266.8811529.57
EXPENDITURE :      
Raw Materials 4963.575041.164676.904709.644264.174235.99
Power & Fuel Cost414.63444.41447.42418.45389.54416.26
Employee Cost 2312.072095.511934.141918.161695.861703.22
Other Manufacturing Expenses 1268.191182.521155.601209.091135.791108.70
Selling and Administration Expenses 2349.232264.541797.131573.221355.011557.70
Miscellaneous Expenses 382.24204.01162.951976.35253.36884.11
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure11689.9311232.1510174.1411804.919093.739905.98
Operating Profit5569.313565.791173.92426.132173.151623.59
Interest 84.5056.3598.4473.4740.6252.59
Gross Profit5484.813509.441075.48352.662132.531571.00
Depreciation647.69724.75548.34514.19502.83518.75
Profit Before Tax4837.122784.69527.14-161.531629.701052.25
Tax857.12484.0595.8957.80362.85362.05
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax7.04-25.456.04-30.638.23-37.35
Reported Net Profit3972.962326.09425.21-188.701258.62727.55
Extraordinary Items -27.2023.7814.4230.6441.61-425.63
Adjusted Net Profit4000.162302.31410.79-219.341217.011153.18
Adjst. below Net Profit -14.47-8.79-1.392.42-7.89-135.66
P & L Balance brought forward17333.9715274.7115032.7415514.1014535.2514227.34
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 379.01258.04181.85295.08271.88226.30
P & L Balance carried down20913.4517333.9715274.7115032.7415514.1014592.93
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %600.00400.00200.00200.00325.00300.00
Earnings Per Share-Unit Curr87.0151.049.35-4.1527.7416.06
Earnings Per Share(Adj)-Unit Curr87.0151.049.35-4.1527.7416.06
Book Value-Unit Curr531.72452.12404.66399.34409.20385.72